More recently, detectable levels of hs-cTnT or hs-cTnI have been observed in asymptomatic individuals and in patients with stable coronary artery disease (CAD), which is supposed to reflect ongoing subclinical myocardial damage. This evidence concerns the gene TNNI3 and coronary artery disorder.